Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
1.700
+0.040 (2.41%)
At close: Jan 31, 2025, 4:00 PM
1.690
-0.010 (-0.59%)
After-hours: Jan 31, 2025, 4:42 PM EST
Alaunos Therapeutics Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for TCRT.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for TCRT.
Recommendation Trends
Rating | Mar '23 | Apr '23 | May '23 | Jun '23 | Jul '23 | Aug '23 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 1 | 1 | 1 | 0 |
Buy | 3 | 3 | 3 | 3 | 3 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 4 | 4 | 4 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 16, 2023 |
Laidlaw & Co. | Laidlaw & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 15, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $225 | Hold → Strong Buy | Upgrades | $225 | +13,135.29% | May 15, 2023 |
Wells Fargo | Wells Fargo | Buy Initiates $450 | Buy | Initiates | $450 | +26,370.59% | Mar 27, 2023 |
Wells Fargo | Wells Fargo | Buy Initiates $450 | Buy | Initiates | $450 | +26,370.59% | Oct 4, 2022 |
Financial Forecast
Revenue This Year
n/a
from 5.00K
Revenue Next Year
568.06M
EPS This Year
-0.61
from -22.00
EPS Next Year
0.88
from -0.61
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | n/a | 584.8M | n/a |
Avg | n/a | 568.1M | n/a |
Low | n/a | 545.8M | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -0.63 | 0.90 | -0.15 |
Avg | -0.61 | 0.88 | -0.14 |
Low | -0.59 | 0.84 | -0.14 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.